Similar articles for PMID: 18797592

Year	Number of Results
1990	2
1993	1
1994	1
1995	1
1996	10
1997	2
1998	3
1999	2
2000	2
2001	2
2002	1
2004	6
2005	2
2006	4
2007	2
2008	9
2009	4
2010	4
2011	6
2012	3
2013	2
2014	1
2015	4
2016	4
2017	6
2018	3
2019	1
2021	1
2024	0

1

[Safety aspects of treatments with hrGH].

Kochi C. Kochi C. Arq Bras Endocrinol Metabol. 2008 Jul;52(5):850-3. doi: 10.1590/s0004-27302008000500017. Arq Bras Endocrinol Metabol. 2008. PMID: 18797592 Portuguese.

2

[hrGH treatment of glucocorticoid-induced short stature in children].

Martinelli CE Jr, Palhares HM. Martinelli CE Jr, et al. Arq Bras Endocrinol Metabol. 2008 Jul;52(5):809-17. doi: 10.1590/s0004-27302008000500013. Arq Bras Endocrinol Metabol. 2008. PMID: 18797588 Review. Portuguese.

3

Safety of growth hormone treatment of children with idiopathic short stature: the US experience.

Allen DB. Allen DB. Horm Res Paediatr. 2011;76 Suppl 3:45-7. doi: 10.1159/000330159. Epub 2011 Sep 7. Horm Res Paediatr. 2011. PMID: 21912165

4

[News options and preparations in growth hormone therapy].

Aguiar-Oliveira MH, Meneguz-Moreno RA, Nascimento-Junior AC. Aguiar-Oliveira MH, et al. Arq Bras Endocrinol Metabol. 2008 Jul;52(5):917-24. doi: 10.1590/s0004-27302008000500024. Arq Bras Endocrinol Metabol. 2008. PMID: 18797599 Portuguese.

5

Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.

Child CJ, Zimmermann AG, Chrousos GP, Cummings E, Deal CL, Hasegawa T, Jia N, Lawrence S, Linglart A, Loche S, Maghnie M, Pérez Sánchez J, Polak M, Predieri B, Richter-Unruh A, Rosenfeld RG, Yeste D, Yorifuji T, Blum WF. Child CJ, et al. J Clin Endocrinol Metab. 2019 Feb 1;104(2):379-389. doi: 10.1210/jc.2018-01189. J Clin Endocrinol Metab. 2019. PMID: 30219920 Free PMC article.

6

Long-term safety of recombinant human growth hormone in children.

Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Bell J, et al. J Clin Endocrinol Metab. 2010 Jan;95(1):167-77. doi: 10.1210/jc.2009-0178. Epub 2009 Nov 11. J Clin Endocrinol Metab. 2010. PMID: 19906787

7

Safety of recombinant human growth hormone in treating children with growth hormone deficiency and idiopathic short stature.

Chang S, Hui P. Chang S, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011 Apr;33(2):123-6. doi: 10.3881/j.issn.1000-503X.2011.02.005. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2011. PMID: 21529437

8

[Growth hormone deficiency in adulthood: how to diagnose and when to treat?].

Jallad RS, Bronstein MD. Jallad RS, et al. Arq Bras Endocrinol Metabol. 2008 Jul;52(5):861-71. doi: 10.1590/s0004-27302008000500019. Arq Bras Endocrinol Metabol. 2008. PMID: 18797594 Review. Portuguese.

9

Benign intracranial hypertension (pseudotumour cerebri) during rhGH therapy.

Querfeld U. Querfeld U. Br J Clin Pract Suppl. 1996 Aug;85:68. Br J Clin Pract Suppl. 1996. PMID: 8995039 No abstract available.

10

Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study.

Quigley CA, Child CJ, Zimmermann AG, Rosenfeld RG, Robison LL, Blum WF. Quigley CA, et al. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3195-3205. doi: 10.1210/jc.2017-00214. J Clin Endocrinol Metab. 2017. PMID: 28575299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year